Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.56 |
| ▸ | PGR | P06401 | 4/20 | 0.56 |
| ▸ | TYMS | P04818 | 3/20 | 0.52 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.52 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.52 |
| ▸ | DPP4 | P27487 | 1/20 | 0.50 |
| ▸ | HSPA1A | P0DMV8 | 1/20 | 0.49 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16863011 | 0.87 | HSPA1A (0.67) | ADORA2APGRDPP4HSPA1APABPC1 | |
| SCHEMBL14029131 | 0.83 | ADORA2A (0.79) | ADORA2ATYMSGRM1GRM4DPP4 | |
| SCHEMBL11520347 | 0.81 | PGR (0.63) | PGR | |
| SCHEMBL29032513 | 0.78 | HSPA1A (0.55) | ADORA2APGRHSPA1APABPC1 | |
| SCHEMBL16863041 | 0.78 | KDM4E (0.58) | ADORA2APGR | |
| SCHEMBL5573414 | 0.74 | POLB (0.58) | PGR | |
| SCHEMBL17622251 | 0.73 | PGR (0.44) | ADORA2APGRHSPA1APABPC1 | |
| SCHEMBL16863029 | 0.72 | HSPA1A (0.63) | ADORA2ATYMSDPP4HSPA1APABPC1 | |
| SCHEMBL31061260 | 0.72 | ADORA2A (1.00) | ADORA2APGRDPP4HSPA1APABPC1 | |
| SCHEMBL11018522 | 0.72 | DPP4 (0.63) | TYMSDPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |
| CN-1181091-C | Factor Xa inhibitors | ������̩�¹�˾ | 2004-12-22 | — | — | CN | disclosed |
| CN-1172905-C | Process for producing cyanobenzylamine salt | �Ѻ͵繤��ʽ���� | 2004-10-27 | — | — | CN | disclosed |
| CN-1341096-A | Process for producing cyanobenzylamine salt | SHOWA DENKO KK (JP) | 2002-03-20 | — | — | CN | disclosed |
| CN-1147261-A | Factor Xa inhibitors | SELECTIDE CORP (US) | 1997-04-09 | — | — | CN | disclosed |